TY - JOUR
T1 - Improving indoor air quality through an air purifier able to reduce aerosol particulate matter (PM) and volatile organic compounds (VOCs)
T2 - Experimental results
AU - Fermo, Paola
AU - Artíñano, Begoña
AU - De Gennaro, Gianluigi
AU - Pantaleo, Antonio Marco
AU - Parente, Alessandro
AU - Battaglia, Fiorella
AU - Colicino, Elena
AU - Di Tanna, Gianluca
AU - Goncalves da Silva Junior, Andouglas
AU - Pereira, Igor Gadelha
AU - Garcia, Gabriel Santos
AU - Garcia Goncalves, Luiz Marcos
AU - Comite, Valeria
AU - Miani, Alessandro
N1 - Publisher Copyright:
© 2021
PY - 2021/6
Y1 - 2021/6
N2 - The adverse effects of fine particulate matter (PM) and many volatile organic compounds (VOCs) on human health are well known. Fine particles are, in fact, those most capable of penetrating in depth into the respiratory system. People spend most of their time indoors where concentrations of some pollutants are sometimes higher than outdoors. Therefore, there is the need to ensure a healthy indoor environment and for this purpose the use of an air purifier can be a valuable aid especially now since it was demonstrated that indoor air quality has a high impact on spreading of viral infections such as that due to SARS-COVID19. In this study, we tested a commercial system that can be used as an air purifier. In particular it was verified its efficiency in reducing concentrations of PM10 (particles with aerodynamic diameter less than 10 μm), PM2.5 (particles with aerodynamic diameter less than 2.5 μm), PM1 (particles with aerodynamic diameter less than 1 μm), and particles number in the range 0.3 μm–10 μm. Furthermore, its capacity in reducing VOCs concentration was also checked. PM measurements were carried out by means of a portable optical particle counter (OPC) instrument simulating the working conditions typical of a household environment. In particular we showed that the tested air purifier significantly reduced both PM10 and PM2.5 by 16.8 and 7.25 times respectively that corresponds to a reduction of about 90% and 80%. A clear reduction of VOCs concentrations was also observed since a decrease of over 50% of these gaseous substances was achieved.
AB - The adverse effects of fine particulate matter (PM) and many volatile organic compounds (VOCs) on human health are well known. Fine particles are, in fact, those most capable of penetrating in depth into the respiratory system. People spend most of their time indoors where concentrations of some pollutants are sometimes higher than outdoors. Therefore, there is the need to ensure a healthy indoor environment and for this purpose the use of an air purifier can be a valuable aid especially now since it was demonstrated that indoor air quality has a high impact on spreading of viral infections such as that due to SARS-COVID19. In this study, we tested a commercial system that can be used as an air purifier. In particular it was verified its efficiency in reducing concentrations of PM10 (particles with aerodynamic diameter less than 10 μm), PM2.5 (particles with aerodynamic diameter less than 2.5 μm), PM1 (particles with aerodynamic diameter less than 1 μm), and particles number in the range 0.3 μm–10 μm. Furthermore, its capacity in reducing VOCs concentration was also checked. PM measurements were carried out by means of a portable optical particle counter (OPC) instrument simulating the working conditions typical of a household environment. In particular we showed that the tested air purifier significantly reduced both PM10 and PM2.5 by 16.8 and 7.25 times respectively that corresponds to a reduction of about 90% and 80%. A clear reduction of VOCs concentrations was also observed since a decrease of over 50% of these gaseous substances was achieved.
KW - Air cleaner
KW - Indoor air quality
KW - Particulate matter
UR - http://www.scopus.com/inward/record.url?scp=85104635919&partnerID=8YFLogxK
U2 - 10.1016/j.envres.2021.111131
DO - 10.1016/j.envres.2021.111131
M3 - Article
C2 - 33865819
AN - SCOPUS:85104635919
SN - 0013-9351
VL - 197
JO - Environmental Research
JF - Environmental Research
M1 - 111131
ER -